1
| PULMONARY ARTERIAL HYPERTENSION (PAH)
STATE OF THE SCIENCE
 
Victor F. Tapson, MD, FCCP, FRCP
Pulmonary/Critical Care Division, Cedars-Sinai Medical Center, Los Angeles, CA USA
2
| TREPROSTINIL IS VERSATILE
 
Leigh Peterson, PhD
Vice President, Product Development, United Therapeutics Corporation
3
| THE BEAT COMBINATION STUDY
 
Jordan Shin MD, PhD
Medical Director, Lung Biotechnology PBC
4
| TREVYENT®
Parenteral Treprostinil Sodium
 
Jonathan M.N. Rigby
President and Chief Executive Officer, SteadyMed
5
| TECHNOSPHERE®
Drug Delivery Platform
 
Michael Castagna, PharmD
Chief Executive Officer, Mannkind Corporation
6
| RESTORATIVE MEDICINE PLATFORM FOR:
Degenerative Diseases, Oncology and Other Proliferative Indications, and Inflammatory Conditions
 
Osman Kibar, PhD
Founder and Chief Executive Officer, Samumed, LLC
7
| THE SAPPHIRE STUDY
Progenitor NO Corundum
 
Jordan Shin MD, PhD
Medical Director, Lung Biotechnology PBC
8
| THE SOUTHPAW STUDY
Heart Failure and Preserved Ejection Fraction: Clinical Study Design and Treatment
 
Mardi Gomberg-Maitland, MD, MSc
Professor of Medicine, Inova Heart and Vascular Institute, VA USA
9
| THE iTRE STUDY
Therapeutic Opportunity for Inhaled Treprostinil in Patients with PH Secondary to Primary Pulmonary Vascular Disease
 
Aaron B. Waxman, MD, PhD, FACP, FCCP
Pulmonary and Critical Care Medicine, Director, Pulmonary Vascular Disease Program, Executive Director, Center for Pulmonary-Heart Diseases, Brigham and Women’s Hospital Heart and Vascular Center; Associate Professor of Medicine, Harvard Medical School
10
| THE INCREASE STUDY
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease (PH-ILD)
 
Peter Smith, PharmD
Senior Director, Product Development, United Therapeutics Corporation
11
| THE PERFECT STUDY
Pulmonary Hypertension (PH) Enrichment Study for Evaluation of COPD with Inhaled Treprostinil
 
Aaron B. Waxman, MD, PhD, FACP, FCCP
Pulmonary and Critical Care Medicine, Director, Pulmonary Vascular Disease Program, Executive Director, Center for Pulmonary-Heart Diseases, Brigham and Women’s Hospital Heart and Vascular Center; Associate Professor of Medicine, Harvard Medical School
12
| ORGAN MANUFACTURING
The Vision to a Cure with an Unlimited Supply of Organs
 
Martine Rothblatt, PhD
Chairman and Chief Executive Officer, United Therapeutics Corporation
13
| 2018 MORNING SESSION WEBCAST
 
14
| 2018 AFTERNOON SESSION WEBCAST